CAROL PINDER: Open Payments
NPI 1154365476 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 18 payments from 10 companies in 2025. Trend: 2023 $347 · 2024 $324 · 2025 $384
Food & beverage: $346Education: $38
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $67 |
| Astellas Pharma US Inc | 2 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| ABBVIE INC. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Exact Sciences Corporation | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Amgen Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: MOUNJARO, Veozah, JARDIANCE, VRAYLAR, CAPLYTA, The Cologuard Plus Collection Kit, AIRSUPRA, OTEZLA.
Industry payments across FL — which companies pay providers there.
